80071873 - 26th Annual Current Topics in Gastrointestinal and Liver Pathology

Saturday, October 31, 2026, 8:00 AM - Sunday, November 1, 2026, 6:50 PM, Online


This 26th annual conference is intended as a practical overview for pathologists who encounter gastrointestinal, liver, and pancreatobiliary specimens in daily practice. Interpretation of biopsy and resection specimens will be addressed, as well as recent advances in ancillary testing and molecular diagnostics. Case presentations will be featured to apply presented concepts. Participants should come away with a better understanding of the diagnostic approach to nonneoplastic and neoplastic specimens and the application of modern molecular techniques.

1. Recognize the histologic features of each of the common patterns of medical liver disease, and the differential diagnostic considerations for each pattern.
2. Discuss the evolving role of liver biopsy in the management of patients with steatotic liver diseases.
3. Assess the utility of routine, special and immunohistochemical stains in constructing a final diagnosis for a liver mass directed biopsy.
4. Discuss how to diagnose Barrett esophagus and assess for dysplasia.
5. Recognize key gastric carcinoma precursors.
6. Recognize and classify the morphologic spectrum of inflammatory bowel disease associated dysplasia, including conventional and nonconventional patterns.
7. Identify the genomic biomarkers for targeted colon cancer therapies.
8. Implement targeted formatting and plain language strategies in gastrointestinal and liver pathology reporting.
9. Recognize the major histologic patterns of drug induced injury in the gastrointestinal tract.
10. Differentiate between low grade appendiceal mucinous neoplasm (LAMN), high grade appendiceal mucinous neoplasm (HAMN), and mucinous adenocarcinoma of the appendix.
11. Name the most common reporting system for anal cytology specimens.
12. Review the classification and grading framework for neuroendocrine neoplasms of the gastrointestinal tract.
13. List the major neoplasms in the differential diagnosis for solid cellular neoplasms of the pancreas.
14. Apply the updated WHO 6th edition classification and terminology for lesions of the extrahepatic biliary tract and gallbladder in routine practice.

Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 16.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits

This activity has been registered to offer credit in the American Board of Pathology (ABPath) Maintenance of Certification program for Lifelong Learning (CME) for up to 16.75 credits.

POLICY ON PRESENTER AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies in place to mitigate relevant conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

JOHNS HOPKINS STATEMENT OF RESPONSIBILITY
The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

COPYRIGHT
All rights reserved - The Johns Hopkins School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

INTERNET CME POLICY
The Office of Continuing Medical Education (OCME) at the Johns Hopkins School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins School of Medicine OCME maintains its internet site as an information resource and service for physicians, other health professionals and the public. OCME at the Johns Hopkins School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins School of Medicine CME program. CME collects only the information necessary to provide you with the services that you request.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This activity is produced for educational purposes only. Use of Johns Hopkins School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

HARDWARE/SOFTWARE REQUIREMENTS
Internet connection.

AMERICANS WITH DISABILITIES ACT
The Johns Hopkins School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.

Mitigation of Relevant Financial Relationships

Johns Hopkins University adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.